期刊文献+

3.0T MR DWI预测鼻咽癌放化疗敏感性的研究 被引量:7

The value of diffusion-weighted of 3.0 T MR imaging for the prediction of chemoradiotherapy sensitivity in nasopharyngeal carcinoma
在线阅读 下载PDF
导出
摘要 目的探讨3.0 T MR扩散加权成像(DWI)在评估鼻咽癌(NPC)放化疗(CRT)疗效中的价值,预测NPC对CRT的敏感性。方法收集32例经病理证实的NPC病人,行常规MRI及DWI检查,测量CRT前与CRT5周时NPC及转移性淋巴结最大者的体积和ADC值。以CRT后1个月病理活检和MRI检查作为疗效评价标准将NPC分为低敏感与高敏感组,比较CRT 5周时NPC低敏感组与高敏感组ADC值、治疗前后ADC值变化率(ΔADC)及体积消退率(ΔV)的差异;分析影响NPC CRT敏感性的相关因素。结果CRT 5周时NPC ADC值、ΔADC及ΔV在高、低敏感组之间差异均有统计学意义(P<0.05),ΔADC为鉴别低敏感与高敏感组最佳指标,其截断值为98.125%,敏感度为95.5%,特异度为90%。非线性Logistic回归分析影响NPC CRT敏感性的相关因素(性别、年龄、治疗方式、T分期及ΔADC),结果显示ΔADC是影响NPC CRT敏感程度的独立预后因素,其相对风险度为1.155。结论 DWI对于评价NPC CRT疗效有重要作用。CRT 5周时NPC ADC值、ΔADC及ΔV都能有效预测NPC CRT敏感性,ΔADC是预测NPC CRT敏感性的最佳指标及独立预后因素。 Objebtive To investigate the value of diffusion-weighted 3.0 T MR imaging (DW-MRI) for evaluating therapeutic effect of chemoradiotherapy (CRT) and predicting sensitivity of CRT in nasopharyngeal carcinoma (NPC). Methods Thirty-two cases with NPC confirmed by pathological biopsy underwent conventional MRI and DWI. We measured the apparent diffusion coefficient (ADC) values before and 5 weeks after CRT. At the same time, the volume of NPC primary tumors and metastatic lymph nodes were measured. Thirty-two cases were grouped into hypersensitivity and hyposensitivity groups based on pathologicaly and MRI findings after a month of therapy. The ADC values, change rate of ADC values (△ADC), and volume of faded rate (△V) during the 5 weeks were compared between the hypersensitivity and hyposensitivity groups. Logistic regression analysis was used to determine sensitive factors for in NPC chemoradiotherapy. Results The ADC, △ADC and △V value of NPC were statistically difference between hypersensitivity and hyposensitivity groups (P〈0.05) at 5 weeks afer CRT. The △ADC was the best measure to discriminate the two groups (cutoff 98.125%, sensitivity, 95.5%, specificity,90%). Nonlinear Logistic regression analysis including sex, age, treatment, T stage, and △ADC showed that △ADC was dependent variable for effecting CRT sensitivity of NPC ( relative risk,1.155). Conclusion DWI has an important role in evaluating therapeutic effect of CRT in NPC. The ADC value, △ADC, and △V of NPC at 5 weeks after CRT could predict the CRT sensitivity. The △ADC is the best indicator in predicting CRT sensitivity, and is a dependent variable for effecting CRT sensitivity in NPC.
出处 《国际医学放射学杂志》 2016年第1期1-5,共5页 International Journal of Medical Radiology
关键词 鼻咽癌 扩散加权成像 表观扩散系数 放化疗 敏感性 Nasopharyngeal carcinoma Diffusion-weighted imaging Apparent diffusion coefficient Chemoradiotherapy Sensitivity
  • 相关文献

参考文献17

  • 1King AD, Chow KK, Yu KH, et al. Head and neck squamous cellcarcinoma: diagnostic performance of diffusion -weighted MRimaging for the prediction of treatment response[J]. Radiology,2013,266:531-538.
  • 2陈明,邢伟,陈杰,生晶,田建明.扩散加权成像评价放射治疗鼻咽癌伴颈部转移性淋巴结疗效[J].中国医学影像技术,2011,27(3):515-519. 被引量:16
  • 3聂翔,李金高.鼻咽癌磁共振弥散加权成像与放疗疗效的相关性研究[J].实用癌症杂志,2011,26(6):627-629. 被引量:11
  • 4Pan J, Zang L, Zhang Y, et al. Early changes in apparent diffusioncoefficients predict radiosensitivity of human nasopharyngealcarcinoma xenografts[J]. Laryngoscope,2012,122:839-843.
  • 5Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of dif-fusion -weighted magnetic resonance imaging during chemoradio-therapy for head and neck squamous cell carcinoma[J]. Eur Radiol,2010,20:1703-1714.
  • 6Eisenhauer EA, Therasse P, Bogaerts J, et al. New responseevaluation criteria in solid tumours: revised RECIST guideline(version 1.1)[J]. Eur J Cancer, 2009,45:228-247.
  • 7Thoeny HC, Ross BD. Predicting and monitoring cancer treatmentresponse with diffusion - weighted MRI[J]. J Magn Reson Imaging,2010,32:2-16.
  • 8Chen J, Sheng J, Xing W, et al. Monitoring early response of lymphnode metastases to radiotherapy in animal models: diffusion -weighted imaging vs. morphological MR imaging [J]. Acta Radiol,2011,52:989-994.
  • 9Hamstra DA, Lee KC, Moffat BA, et al. Diffusion magneticresonance imaging: an imaging treatment response biomarker tochemoradiotherapy in a mouse model of squamous cell cancer of thehead and neck[J]. Transl Oncol,2008,1:187-194.
  • 10Wilhelm T, Stieltjes B, Schlemmer HP. Whole-body-MR-diffusionweighted imaging in oncology[J], Rofo,2013,185:950-958.

二级参考文献17

  • 1易俊林,高黎,黄晓东,李素艳,罗京伟,徐国镇.鼻咽癌放射治疗的失败模式[J].中华放射肿瘤学杂志,2004,13(3):145-148. 被引量:89
  • 2肖建平,徐国镇,高黎,秦德兴,蔡伟民,李素艳.鼻咽癌初程放疗后残存的分次X刀治疗初探[J].中华放射肿瘤学杂志,2005,14(2):77-80. 被引量:24
  • 3刘妍,夏黎明,邹明丽,王承缘.磁共振扩散加权成像及ADC值测量在淋巴结病变鉴别诊断中的价值[J].中国医学影像技术,2006,22(5):730-732. 被引量:47
  • 4张赟,梁碧玲,高立,钟镜联,叶瑞心,沈君.磁共振弥散加权成像诊断颈部淋巴结的临床价值[J].中华肿瘤杂志,2007,29(1):70-73. 被引量:48
  • 5Bradford A, Moffat, Chenevert, et al. Functional diffusion m- ap:a noninvasive MRI biomarker for early stratification of clinical brain tumor response [ J ]. PNAS, 2005,102 ( 15 ) : 5524.
  • 6Kuei Lee, Daniel E, Benjamin A. Dynamic imaging of emer- ging resistance during cancer therapy[ J]. Cancer Res,2006, 66(9) :55.
  • 7Duong TQ, Ackermann JH, Ying HS, et al. Evaluation of ex- tra- and intracellular apparent diffusion in normal and global-ly ischemic rat brain via 19F NMR[J]. Magn Reson Med, 1998,40(28) :12.
  • 8Safer A, Zhong J, Gore JC, et al. Theoretical model for water diffusion in tissues [ J]. nagn Reson ned, 1995,23 ( 33 ) : 697.
  • 9Dow-mu koh, David M, Gore T, et al. Diffusion-weighted MRI in the body: applications and challenges in oncology [ J]. Magnetic Resonance Imaging,2007,127 ( 25 ) :446.
  • 10Kuei C. Lee Sudha, Charles R, et al. An imaging biomarker of early treatment response in prostate cancer that has metasta- sized to the bone [ J ]. Cancer Res,2007,67 ( 8 ) : 3524.

共引文献37

同被引文献58

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部